Showing results (411-420 of 534) with videos related to
Sort By:
Pageof 54
Journal of the American College of Cardiology|June 21, 2005
Use of bivalirudin during percutaneous coronary intervention in patients with diabetes mellitus: an analysis from the randomized evaluation in percutaneous coronary intervention linking angiomax to reduced clinical events (REPLACE)-2 trialHitinder S Gurm, Ian J Sarembock, Dean J Kereiakes, et al.The American Journal of Medicine|January 25, 2006
Differences in the clinical features and outcomes in African Americans and whites with myocardial infarctionRajendra H Mehta, David Marks, Robert M Califf, et al.The American Journal of Cardiology|July 16, 2003
Effect of abciximab versus tirofiban on activated clotting time during percutaneous intervention and its relation to clinical outcomes--observations from the TARGET trialIvan P Casserly, Eric J Topol, Gang Jia, et al.American Heart Journal|July 3, 2002
Predicting outcome after thrombolysis in acute myocardial infarction according to ST-segment resolution at 90 minutes: a substudy of the GUSTO-III trial. Global Use of Strategies To Open occluded coronary arteriesR David Anderson, Harvey D White, E Magnus Ohman, et al.American Heart Journal|January 7, 2003
Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: lessons from 4 international fibrinolytic therapy trialsDavid Hasdai, Eric J Topol, Rakhi Kilaru, et al.Proceedings of the National Academy of Sciences of the United States of America|September 1, 2009
A common MECP2 haplotype associates with reduced cortical surface area in humans in two independent populationsAlexander H Joyner, Cooper Roddey J, Cinnamon S Bloss, et al.Journal of the American College of Cardiology|January 5, 2002
Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stentingDeepak L Bhatt, Michel E Bertrand, Peter B Berger, et al.The American Journal of Cardiology|May 21, 2005
Association of height with outcomes in patients with acute myocardial infarction receiving reperfusion therapyRajendra H Mehta, Robert M Califf, Jyotsna Garg, et al.Circulation|April 30, 2003
Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injuryZhongmin Zhou, Kai Wang, Marc S Penn, et al.Journal of the American College of Cardiology|February 2, 2002
Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarction: the integrilin and low-dose thrombolysis in acute myocardial infarction (INTRO AMI) trialSorin J Brener, Uwe Zeymer, A A Jennifer Adgey, et al.Pageof 54